Trial updateRetina
NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration
Active, not recruiting. Phase 1 / Phase 2. Registered enrolment: 20. Elisigen, Inc.
Why it matters
Track this study through NCT05984927. No results are posted in this registry record.
The study at a glance
- Registry status
- Active, not recruiting
- Phase
- Phase 1 / Phase 2
- Registered enrolment
- 20
- Results posted
- No
- Sponsor
- Elisigen, Inc.
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.